ArticleThe Korean journal of internal medicine2022
Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis.
Kichul Shin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.